An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema
- Status
- UNKNOWN
- Phase
- PHASE4
Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative
- Status
- COMPLETED
- Phase
- PHASE2
Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE3
The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older
- Status
- COMPLETED
- Phase
- N/A
Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
- Status
- COMPLETED
- Phase
- PHASE1
Intranasal Bevacizumab for HHT-Related Epistaxis
- Status
- COMPLETED
- Phase
- PHASE4
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
- Status
- TERMINATED
- Phase
- PHASE2
INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24)
- Status
- COMPLETED
- Phase
- PHASE2
Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A